U.S., Dec. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07296029) titled 'CONFOCAL-2 Interventional Pilot Study' on March 26.
Brief Summary: This study is designed to assess the feasibility of identifying and administering individualized blood pressure targets early critical illness. Recent literature suggests that individualized targets adapted to cerebral perfusion and autoregulation capacity may improve patient outcomes. In this study, cerebral autoregulation capacity is assessed by simultaneous trending of near-infared spectroscopy and arterial blood pressure for 24 hours, within patients' first 2 days in the ICU. The investigators will assess the feasibility of identifying patients' personal targets,...